Immune system
- Effects of Cannabidiol on Innate Immunity: Experimental Evidence and Clinical Relevance (27 Feb 2023)
- CB2 Cannabinoid Receptors Contribute to Bacterial Invasion and Mortality in Polymicrobial Sepsis (27 Nov 2022)
- Gene Expression Data Mining Reveals the Involvement of GPR55 and Its Endogenous Ligands in Immune Response, Cancer, and Differentiation (01 Sep 2022)
- Endocannabinoid Anandamide Attenuates Acute Respiratory Distress Syndrome through Modulation of Microbiome in the Gut-Lung Axis (01 Sep 2022)
- CB2 Receptor in Microglia: The Guardian of Self-Control (01 Sep 2022)
- Cannabinoids in Medicine: Cancer, Immunity, and Microbial Diseases (27 Aug 2022)
- Anti-Inflammatory and Pro-Autophagy Effects of the Cannabinoid Receptor CB2R: Possibility of Modulation in Type 1 Diabetes (13 Aug 2022)
- Botanically-Derived Δ9-Tetrahydrocannabinol and Cannabidiol, and Their 1:1 Combination, Modulate Toll-like Receptor 3 and 4 Signalling in Immune Cells from People with Multiple Sclerosis (05 Aug 2022)
- A Cannabinoid 2-Selective Agonist Inhibits Allogeneic Skin Graft Rejection In Vivo (05 Aug 2022)
- Cannabidiol and Terpene Formulation Reducing SARS-CoV-2 Infectivity Tackling a Therapeutic Strategy (26 Jul 2022)
- Cannabis & the Immune System: A Complex Balancing Act (21 Jul 2022)
- Kashanchi and Liotta studying effect of cannabidiol on exosome release (18 Jul 2022)
- CBD may help avert lung destruction in COVID-19 (18 Jul 2022)